Biology Reference
In-Depth Information
Amadori A, De Silvestro G, Zamarchi R, Veronese ML, Mazza MR, Schiavo G, Panozzo M, De
Rossi A, Ometto L, Mous J. 1992. CD4 epitope masking by gp120/anti-gp120 antibody com-
plexes. A potential mechanism for CD4
cell function down-regulation in AIDS patients. J
Immunol 148: 2709±2716.
Andre P, Brunet C, Guia S, Gallas H, Sampol J, Vivier E, Dignat-George F. 1999. Di¨erential
regulation of killer cell Ig-like receptors and CD94 lectin-like dimmers on NK and T lympho-
cytes from HIV-1-infected individuals. Eur J Immunol 29: 1076±1085.
Arase H, Arase N, Kobayashi Y, Nishimura Y, Yonehara S, Onoe K. 1994. Cytotoxicity of fresh
NK1.1
T cell receptor alpha/beta
thymocytes against a CD4
8
thymocyte population
associated with intact Fas antigen expression on the target. J Exp Med 180: 423±432.
Badley AD, Pilon AA, Landay A, Lynch DH. 2000. Mechanisms of HIV-associated lymphocyte
apoptosis. Blood 96: 2951±2964.
Baldwin GC, Roth MD, Tashkin DP. 1998. Acute and chronic e¨ects of cocaine on the immune
system and the possible link to AIDS. J Neuroimmunol 83: 133±138.
Bennett M, Yu YY, Stoneman E, Rembecki RM, Mathew PA, Lindahl KF, Kumar V. 1995. Hy-
brid resistance: `negative' and `positive' signaling of murine natural killer cells. Semin Immunol
7: 121±127.
Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A,
Moretta L. 1996. The human leukocyte antigen (HLA)-C-speci®c ``activatory'' or ``inhibitory''
natural killer cell receptors display highly homologous extracellular domains but di¨er in their
transmembrane and intracytoplasmic portions. J Exp Med 183: 645±650.
Blumberg RS, Paradis T, Hartshorn KL, Vogt M, Ho DD, Hirsch MS, Leban J, Sato VL, Schooley
RT. 1987. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human
immunode®ciency virus. J Infect Dis 156: 878±884.
Bonavida B, Katz J, Gottlieb M. 1986. Mechanism with defective NK cell activity in patients with
acquired immunode®ency syndrome (AIDS) and AIDS-related complex I. Defective trigger on
NK cells for NKCF production by target cells and partial restoration by IL-2. J Immunol 137:
1157±1163.
Bonavida B, Ng C-P, Jazirehi A, Schiller G, Mizutani Y. 1999. Selectivity of TRAIL-mediated
apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics. Int J
Oncol 15: 793±802.
Bottino C, Vitale M, Pende D, Biassoni R, Moretta A. 1995. Receptors for HLA class I molecules
in human NK cells. Semin Immunol 7: 67±73.
Bradley TP, Bonavida B. 1982. Mechanism of cell-mediated cytotoxicity at the single cell level. IV.
Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same
human e¨ector cell as determined by the two-target conjugate assay. J Immunol 129: 2260±
2265.
Brasel K, McKenna HJ, Morrissey PJ, Charrier K, Morris AE, Lee CC, Williams DE, Lyman SD.
1996. Hematologic e¨ects of ¯t3 ligand in vivo in mice. Blood 88: 2004±2012.
Bruunsgaard H, Pedersen C, Skinhoj P, Pedersen BK. 1997. Clinical progression of HIV infection:
role of NK cells. Scand J Immunol 46: 91±95.
Collins KL, Baltimore D. 1999. HIV's evasion of the cellular immune response. Immunol Rev 168:
65±74.
Daniel V, Susal C, Weimer R, Zimmermann R, Huth-Kuhne A, Opelz G. 1993. Association of T
cell and macrophage dysfunction with surface gp120-immunoglobulin-complement complexes in
HIV-infected patients. Clin Exp Immunol 93: 152±156.
De Maria A, Moretta L. 2000. HLA-class I-speci®c inhibitory receptors in HIV-1 infection. Hum
Immunol 61: 74±81.
Dunn PL, North RJ. 1991. Early gamma interferon production by natural killer cells is important
in defense against murine listeriosis. Infect Immun 59: 2892±2900.
